Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM.
Rubin MA, et al. Among authors: varambally s.
Cancer Res. 2004 Jun 1;64(11):3814-22. doi: 10.1158/0008-5472.CAN-03-3881.
Cancer Res. 2004.
PMID: 15172988